| Open-market activity | Bought | Sold | Net | Trades |
|---|---|---|---|---|
| Last 3 months | ₹0 | ₹0 | ₹0 | 0 buys, 0 sales |
| Last 6 months | ₹0 | ₹0 | ₹0 | 0 buys, 0 sales |
| Last 12 months | ₹0 | ₹0 | ₹0 | 10 buys, 0 sales |
Open-market = purchases on the market and sales on or off the market. ESOP exercises, gifts, transfers inside the promoter group and pledges are listed below but not counted as buying or selling. Latest filing 3 Apr 2026.
| Filed | Acquirer | Direction | Mode | Acquired | Sold | Holding after | Promoter |
|---|---|---|---|---|---|---|---|
| 25 Sep 2026 | Catalyst Trusteeship Limited Reg29(2) |
Acquisition | Others | 53,540,000 3.85% |
— | 8.39% | No |
| 24 Sep 2026 | Catalyst Trusteeship Limited Reg29(2) |
Acquisition | Others | 44,365,440 3.19% |
— | 16.14% | No |
| 23 Sep 2026 | Catalyst Trusteeship Limited Reg29(2) |
Sale | Others | — | 44,365,440 3.19% |
12.95% | No |
| 22 Sep 2026 | Catalyst Trusteeship Limited Reg29(2) |
Sale | Others | — | 53,540,000 3.85% |
4.54% | No |
| 5 Aug 2026 | Catalyst Trusteeship Limited acting as Debenture Trustee on behalf of Debenture holders Reg29(2) |
Sale | Others | — | 33,634,560 2.42% |
16.14% | No |
| 16 Jul 2026 | Catalyst Trusteeship Limited Reg29(2) |
Sale | Others | — | 30,000,000 2.16% |
8.28% | No |
| 2 Apr 2026 | Catalyst Trusteeship Limited Reg29(2) |
Acquisition | Others | 43,540,000 3.13% |
— | 10.55% | No |
| 2 Apr 2026 | Catalyst Trusteeship Limited Reg29(2) |
Acquisition | Others | 33,500,000 2.41% |
— | 18.56% | Yes |
| 27 Mar 2026 | Catalyst Trusteeship Limited acting as Debenture Trustee on behalf of Debenture holders Reg29(2) |
Acquisition | Others | 44,500,000 3.20% |
— | 16.15% | No |
| 2 Jan 2026 | Catalyst Trusteeship Limited Reg29(2) |
Acquisition | Others | 40,000,000 2.88% |
— | 7.41% | No |
Showing the most recent disclosures only. Sign in to see more, or upgrade your plan to see the full history. Sign in
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.